Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this pilot study is to investigate the safety and tolerability after multiple oral doses of BAY 1142524 administered BID (using 3 dose groups) or OD (using a 4th dose group) as combinations of 5 and 50 mg IR tablets for 14 days in 12 patients with left-ventricular dysfunction after myocardial infarction (9 verum and 3 placebo) per dose group in comparison to placebo in a randomized, single blind group-comparison design.
Critère d'inclusion
- left-ventricular dysfunction after myocardial infarction